Ratings by Raymond James (Tiago Fauth)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/7/2026 | Rapport Therapeutics | RAPP | Maintain | Strong Buy (N/A) |
|
Details | ||
| 4/9/2026 | PTC Therapeutics | PTCT | New Coverage | Outperform (N/A) |
71.26 (78.98) |
10.83% | Details | |
| 4/9/2026 | Jazz Pharmaceuticals | JAZZ | New Coverage | Outperform (N/A) |
195.93 (224.66) |
14.66% | Details | |
| 4/9/2026 | Praxis Precision Medicines Inc. | PRAX | New Coverage | Strong Buy (N/A) |
320.22 (282.31) |
-11.84% | Details | |
| 4/9/2026 | Ionis Pharmaceuticals | IONS | New Coverage | Outperform (N/A) |
74.98 (74.12) |
-1.15% | Details | |
| 4/9/2026 | Insmed | INSM | New Coverage | Outperform (N/A) |
160.18 (95.80) |
-40.19% | Details | |
| 4/9/2026 | Rapport Therapeutics | RAPP | New Coverage | Strong Buy (N/A) |
33.69 (37.34) |
10.83% | Details | |
| 4/9/2026 | United Therapeutics Corp. | UTHR | New Coverage | Outperform (N/A) |
581.69 (536.59) |
-7.75% | Details |
